BC
ELV icon

Barnett & Company’s Elevance Health ELV Stock Holding History

Barnett & Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12
Closed -$3K – 308
2018
Q4 		$3K Hold
12
– – ﹤0.01% 304
2018
Q3 		$3K Hold
12
– – ﹤0.01% 329
2018
Q2 		$3K Buy
+12
New +$2.78K ﹤0.01% 305
2016
Q2 		– Sell
-250
Closed -$35K – 392
2016
Q1 		$35K Buy
+250
New +$33.4K 0.02% 226

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barnett & Company's ELV Position: Q1 2019 in Review

Barnett & Company sold out of Elevance Health (ELV) in Q1 2019, closing a stake of 12 shares — an estimated $3K sold.

Barnett & Company first reported a position in ELV in Q1 2016 and held it in 4 quarters. The position peaked at $35K in Q1 2016. 1,074 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

  • Barnett & Company reported no remaining Elevance Health position as of Q1 2019 after selling out during the quarter.
  • Barnett & Company sold 12 Elevance Health shares in Q1 2019, an estimated $3K.
  • Barnett & Company first reported a position in Elevance Health in Q1 2016 and held it in 4 quarters.
  • Barnett & Company's Elevance Health position peaked at $35K in Q1 2016.
  • 1,074 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Barnett & Company's 13F filing for Q1 2019, filed 26 Apr 2019.